Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

264 results about "Total rna" patented technology

Total RNA. Ribonucleic acid (RNA) is vital to the functioning of life. It is present in every cell in the body and has nearly limitless functions – from carrying genetic information to the production of deoxyribonucleic acid (DNA).

Verification method for gene interference regulation and control of bovine adipocyte proliferation and differentiation

The invention discloses a verification method for regulating and controlling proliferation and differentiation of bovine adipocytes by gene interference, which comprises the following steps: cutting bovine adipocyte tissues into small blocks, directly pasting the small blocks in a culture dish for culture, and promoting cell growth and proliferation by using nutrition and growth factors of the tissues; a ZNF423 gene is targeted by adopting an siRNA technology, siRNA is transfected into bovine fat cells by utilizing a transfection reagent, and the siRNA is an interference fragment containing si-ZNF423; the method comprises the following steps: respectively extracting total RNA (Ribonucleic Acid) and total protein of bovine adipocytes, and detecting by utilizing qPCR (Quantitative Polymerase Chain Reaction) quantitative analysis, a WB (White Batch) technology, EdU dyeing, flow cytometry detection, oil red O, BODIPY (Boron Dipyrromethene), Nile Red dyeing, TG (Triglyceride) content determination and the like. According to the invention, ZNF423 gene expression is interfered by the interference fragment containing si-ZNF423, and the effect of inhibiting proliferation and differentiation of bovine adipocytes is detected by various methods, so that the effect of the interference fragment in the bovine adipocytes is known conveniently, and regulation and control of proliferation and differentiation of the bovine adipocytes are realized by interfering gene expression by the interference fragment. The beef quality can be improved; the beef cattle breeding can be optimized.
Owner:NINGXIA UNIVERSITY +1

Reagent combination and kit for extracting nucleic acid by paramagnetic particle method and application of reagent combination and kit

PendingCN119639732Aprevent oxidative denaturationIntegrity guaranteedDNA preparationFood additiveTotal rna
The invention belongs to the technical field of biology, and particularly relates to a reagent combination and a kit for extracting nucleic acid through a paramagnetic particle method and application of the reagent combination and the kit. The reagent combination or the kit does not adopt beta-mercaptoethanol with pungent smell or dithiothreitol needing to be stored at low temperature as an antioxidant, but adopts tris (2-formylethyl) phosphine hydrochloride and / or metabisulfite as an antioxidant, belongs to common salt chemical reagent powder, can be stored at normal temperature, and can be used for preparing a reagent for the first time. Manual addition by experimenters before an experiment is not needed, so that nucleic acid (RNA) released by splitting decomposition can be effectively prevented from being oxidized and denatured, and the integrity of extracted nucleic acid (total RNA) fragments is ensured; especially, the metabisulfite is commonly used in food additives, does not cause harm to the body, and is non-toxic and non-volatile.
Owner:WUHAN MGI TECH CO LTD

Method for intelligently controlling RNA (Ribonucleic Acid) enzyme reaction by applying Raman

The invention discloses a method for intelligently controlling RNA (Ribonucleic Acid) enzyme reaction by applying Raman, and particularly relates to the fields of molecular biology and biological reaction engineering. Comprising the following specific preparation steps: S1, establishing a reaction model; S2, finding a characteristic peak which is most suitable for tracking; S3, tracking the change of the characteristic peak along with time; S4, comparing a result with a model which is independently calculated by chemometrics; according to the present invention, the enzyme reaction conversion rate can be monitored by using Raman, the reaction process can be subjected to in-situ, real-time, online and non-destructive composition analysis monitoring, and the previous HPLC off-line test is not required; the content of four nucleotides and the reaction conversion rate can be quickly reflected in real time; meanwhile, the reaction can be controlled to a certain degree, the device is communicated with an ultrafiltration device, the enzyme utilization rate is increased, the total RNA reaction amount is increased, the conversion rate is increased, the production cost is saved, and efficient intelligent control is achieved.
Owner:上海蔚之星生物科技有限公司

Biomarker for gastric signet ring cell carcinoma and detection kit thereof

The invention discloses a gastric signet-ring cell carcinoma biomarker and a detection kit thereof, belongs to the technical field of biological medicines, and particularly relates to the detection kit of the gastric signet-ring cell carcinoma biomarker, which comprises a total RNA (Ribonucleic Acid) extraction reagent, an RNA purification reagent, a cDNA (Complementary Deoxyribonucleic Acid) first strand synthesis premixing reagent, a rapid fluorescent quantitative premixing reagent (SYBR Green), nuclease-free double distilled water and a specific primer. The RNA purification reagent at least comprises isopropanol, chloroform and absolute ethyl alcohol; the specific primer comprises an upstream specific primer and a downstream specific primer. The detection kit for the gastric signet-ring cell carcinoma biomarker is high in RNA purification and recovery efficiency and excellent in specificity.
Owner:ZHEJIANG CANCER HOSPITAL

Fluorescent quantitative PCR reference gene screening method in different tissues and stress treatment of perilla frutescens

The invention relates to the technical field of molecular biology, in particular to a fluorescent quantitative PCR reference gene screening method in different tissues and stress treatment of perilla frutescens, which specifically comprises the following steps: step 1, respectively selecting perilla frutescens leaves, stalks, roots, fruits at different development stages after flowering and perilla frutescens leaves treated by 20% PEG6000 for 0H, 3H, 6H, 9H, 12H and 24H as samples; extracting total RNA (Ribonucleic Acid) of each sample, and carrying out reverse transcription on the RNA to synthesize cDNA (Complementary Deoxyribose Nucleic Acid) as And step 2, screening out candidate reference genes of the purple perilla by using the sequencing data of the early-stage purple perilla transcriptome, namely PfActin, Pf18S, PfEF-1alpha, PfCYP, PfTUA, PfTUB and PfGAPDH respectively, and screening out the candidate reference genes of the purple perilla, namely PfActin, Pf18S, PfEF-1alpha, PfCYP, PfTUA, PfTUB and PfGAPDH. According to the method, the most stable reference genes in perilla leaves, stems, roots, fruits in three development stages and perilla leaves treated by 20% PEG6000 for 0H, 3H, 6H, 9H, 12H and 24H are screened from seven candidate reference genes, and a foundation is laid for deep excavation of functional genes in the later period.
Owner:ZHEJIANG FORESTRY UNIVERSITY

Detection method of RNA fusion gene

The invention belongs to the technical field of biology, particularly relates to a detection method of an RNA fusion gene, and more particularly relates to a detection method of an RNA fusion gene based on an FFPE sample source. According to the method, the total RNA is used as a template to build the library, and the step of enriching mRNA or removing rRNA is not needed, so that the experiment time is shortened, and the experiment cost is reduced; according to the invention, a quality control index DV200 of sample RNA and grade division of the sample are provided, so that more accurate library construction of subsequent samples with different quality grades is facilitated; the internal reference quality control product is added in the whole experiment, so that the whole experiment process is better monitored, and the experiment accuracy is improved.
Owner:SANSURE BIOTECH INC +1

Method for detecting cis-platinum resistance of bladder cancer based on exosome miRNA marker and application

The invention relates to the technical field of drug resistance detection, in particular to a method for detecting cis-platinum drug resistance of bladder cancer based on an exosome miRNA marker and application, and the method comprises the following steps: (1) extracting an exosome from serum of a bladder cancer patient; (2) extracting total RNA (Ribonucleic Acid) from the exosome; (3) detecting the expression level of specific miRNA in the total RNA; (4) on the basis of the expression level of the miRNA, the drug resistance risk of a patient to cis-platinum is evaluated, and the prediction accuracy (AUC is increased from 0.72 to 0.89) of the cis-platinum drug resistance of bladder cancer is remarkably improved; compared with the prior art, the treatment effective rate is greatly improved (from 45% to 60%), meanwhile, the occurrence rate of serious adverse reactions is reduced (from 25% to 15%), and in a drug-resistant bladder cancer model, the comprehensive scheme shows that the tumor inhibition rate exceeds 70% and is far higher than that of a traditional method.
Owner:沈德鑫

Method for constructing macro virus group sequencing library for removing host ribosomal RNA (Ribosomal Ribonucleic Acid) by enzyme method and kit

The invention provides a macro virus group sequencing library construction method for removing host ribosome RNA through an enzyme method and a kit, and belongs to the technical field of biology. The method comprises the following steps: hybridizing total RNA (Ribonucleic Acid) of a sample with a DNA (Deoxyribose Nucleic Acid) probe aiming at host ribosome RNA to form a DNA / RNA hybrid chain; rNase H is used for digesting RNA in the hybrid chain, and DNase I is used for digesting the remaining DNA probe in the system; purifying to obtain virus RNA (Ribonucleic Acid); carrying out fragmentation treatment on the virus RNA; carrying out reverse transcription on the fragmented RNA to synthesize a first chain cDNA, then synthesizing a second chain cDNA, and carrying out terminal repair and dA tail addition to obtain double-chain cDNA; connecting the linker with the dT tail with the double-chain cDNA; and carrying out PCR amplification and purification on the connection product to obtain the macro virus group sequencing library. According to the construction method and the kit, the problem that the full-length sequence of the virus cannot be obtained from a low-load sample can be solved.
Owner:ZHEJIANG CENT FOR DISEASE CONTROL & PREVENTION +1

Preparation method and application of siRNA for reducing silkworm moth wing area

The invention discloses a preparation method and application of siRNA (small interfering Ribonucleic Acid) for reducing silkworm moth wing area. The method comprises the following steps: extracting total RNA in a silkworm fat body, and carrying out reverse transcription to obtain first-chain cDNA; carrying out amplification by taking the silkworm Kurtz cDNA as a template to obtain silkworm Kurtz cDNA; carrying out PCR (Polymerase Chain Reaction) amplification by taking the pFLAG-BmKurtz as a template, and connecting a DNA (Deoxyribose Nucleic Acid) fragment with a vector after enzyme digestion to obtain Carrying out PCR (Polymerase Chain Reaction) amplification by taking the DNA as a template to obtain a reaction Mixing the reaction template with the mixed solution to react, and further treating to obtain BmKurtz siRNA; the BmKurtz siRNA is injected into the abdomen of pupated silkworm chrysalis, and the wing area of the pupated silkworm moth is reduced. The method is realized by regulating bombyx mori metabolism, genetic characteristics of bombyx mori are not changed, and research on substance and energy metabolism mechanisms of bombyx mori, regulation of bombyx mori physiological functions and the like is greatly promoted.
Owner:ZHEJIANG UNIV

Detection method of escherichia coli RNA (Ribonucleic Acid) and application thereof

The invention relates to a detection method of escherichia coli RNA (Ribonucleic Acid) and application thereof. Specifically, the invention discloses a quantitative method for rapidly detecting RNA in escherichia coli in a sample. According to the invention, total RNA in Escherichia coli is taken as a standard substance, a qPCR method is used, and the content of Escherichia coli RNA in a sample is quantitatively detected and analyzed, so that whether the sample is polluted by Escherichia coli or not can be determined, the pollution degree can be evaluated, or the residual amount of Escherichia coli RNA in the sample can be determined. The detection sensitivity is high, the detection limit can reach 0.01 pg / microliter, the escherichia coli can be effectively distinguished from RNA of other types and sources, and the specificity is high. The method is wide in application range, simple and rapid to operate and low in cost.
Owner:JIANGSU NUTAI BIOLOGICS CO LTD

Method for eliminating ribosomal RNA in mouse total RNA sample

The invention provides a method for eliminating ribosomal RNA in a mouse total RNA sample, which comprises the following steps: carrying out reverse transcription on the total RNA in the mouse sample into cDNA, and amplifying the cDNA by adopting a primer sequence group to obtain a DNA fragment covering all sequences of the mouse ribosomal RNA; carrying out amplification by taking the DNA fragment as a template and adopting a single primer in the primer sequence group to obtain a single-stranded DNA probe; hybridizing the total RNA of the mouse sample by adopting a single-stranded DNA probe, and performing RNase H digestion to obtain a digestion product; sequentially carrying out DNase I digestion and RNA purification on the digestion product to obtain a target product; wherein the primer sequence group comprises upstream primers from the first to the nineteenth and downstream primers from the first to the nineteenth, and the primer sequence group has the characteristics of low cost, stable performance and high reduction efficiency.
Owner:INSTITUTE OF ANIMAL SCIENCES OF CHINESE ACADEMY OF AGRICULTURAL SCIENCES

Application method for revealing RIPK3 as osteoarthritis pathological index based on transcriptomics analysis

The invention discloses an application method for revealing RIPK3 as a pathological index of osteoarthritis based on transcriptomics analysis, and belongs to the technical field of molecular biology and genetic engineering.The method comprises the following steps that S1, a Trizol reagent is used for conducting total RNA extraction on an articular cartilage specimen, and the RIN number gt is selected; 7.0, constructing a sequencing library by using the high-quality RNA sample; s2, carrying out quality inspection on the constructed library, and carrying out mRNA sequencing by using an Illumina NovaseqTM6000 sequencer after all the libraries are qualified in quality inspection; s3, carrying out bioinformatics analysis on data generated by high-throughput sequencing; s4, different parts of the cartilage tissue of the OA patient are labeled with RIPK3 through immunofluorescence, it is proved that expression of the RIPK3 in cartilage cells has strong correlation with the pathology of the OA focus, and the feasibility of taking the RIPK3 as a clinical pathology index is proved.
Owner:THE FIFTH PEOPLES HOSPITAL OF NINGXIA HUI AUTONOMOUS REGION (NINGXIA HUI AUTONOMOUS REGION NAT MINE MEDICAL RESCUE CENT)

Application of BAY87-2243 and pseudorabies virus inhibition medicine

The invention belongs to the technical field of pseudorabies virus prevention and control, and discloses application of BAY87-2243 in preparation of a drug for inhibiting pseudorabies virus proliferation, and the application is as follows: firstly, PK-15 is infected with a PRV-GD-WH strain, total RNA of cells is taken, and cDNA is obtained through reverse transcription; the change of the transcriptional level of a glycolysis key gene in a cell is detected through fluorescent quantitative PCR (Polymerase Chain Reaction) of an SYBR Green method. BAY87 is further used for acting on the HIF-1alpha, the regulation and control effect of the HIF-1alpha on glycolysis is verified, and finally, the virus load in cells is detected through SYBR Green fluorescent quantitative PCR (Polymerase Chain Reaction) and the inhibition effect of BAY87-2243 on PRV proliferation is determined through TCID50. Meanwhile, the invention also provides a pseudorabies virus inhibition drug.
Owner:INST OF ANIMAL HEALTH GUANGDONG ACADEMY OF AGRI SCI

A kit for detecting total RNA residues of Escherichia coli and its detection method and application

The present invention discloses a kit for detecting residual total RNA of Escherichia coli, a detection method and an application thereof. By designing a pre-treatment system, a plasmid sample can be directly used for quantitative detection of residual total RNA of Escherichia coli by RT-qPCR after digestion. The detection method eliminates the influence of the enzyme digestion process on the detection result by setting a digestion quality control product, ensures the accuracy of the entire detection result, and has excellent specificity, accuracy, sensitivity and precision.
Owner:ZHEJIANG INNOFORCE PHARMACEUTICALS CO LTD

Murine recombinant monoclonal antibody for specifically recognizing African horse pestivirus VP7 protein

The invention belongs to the technical field of immunology and in vitro diagnosis, and particularly relates to a mouse recombinant monoclonal antibody for specifically recognizing African horse pestivirus VP7 protein. According to the invention, a hybridoma cell strain 2C12 for African horse pestivirus VP7 protein is obtained through screening by using a hybridoma cell technology, total RNA is extracted and is subjected to reverse transcription to form cDNA, the cDNA is used as a template and is amplified by using a nested PCR method to obtain light chain and heavy chain variable region sequences of mouse IgG antibody molecules, the light chain and heavy chain variable region sequences are constructed to a plasmid vector containing a mouse source constant region, and the mouse IgG antibody is obtained. And co-transfecting 293F suspension cells for expression and purification to obtain the murine recombinant monoclonal antibody for specifically recognizing the African horse pestivirus VP7 protein. The recombinant antibody can specifically recognize the recombinant VP7 protein of the African horse plague virus, but does not recognize the recombinant VP7 protein of bluetongue virus and epidemic hemorrhagic fever virus, so that support is provided for further establishing a specific African horse plague diagnosis technology.
Owner:LANZHOU VETERINARY RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES(LANZHOU BRANCH CENTER OF CHINA ANIMAL HEALTH & EPIDEMIOLOGY CENTER)

Single bacterium transcriptome sequencing method

The invention discloses a single bacterium transcriptome sequencing method. The method comprises the following steps: firstly, mixing microorganisms and a wrapping material, solidifying to form a jelly-shaped semi-solid, and digesting cell walls by using lysozyme to permeate bacteria; adding a reverse transcription reagent and a random primer, and capturing total RNA in bacteria to synthesize cDNA; dissolving the wrapping material, releasing single bacteria, and packaging the single bacteria and the labeled microbeads into liquid drops by using a microfluidic device; rNA in bacteria is digested through enzyme digestion, so that cDNA is released from the bacteria, the cDNA is collected and purified after demulsification, a sequencing library is constructed through amplification and addition of a sequencing joint, a cDNA product of rRNA is digested, and a cDNA product of mRNA is enriched. And performing high-throughput sequencing on the processed sample, and analyzing transcriptome information of a single microorganism. Microorganisms are wrapped by the reversible solidification porous material, centrifugal cleaning is not needed, and single-bacterium analysis can be carried out on a microorganism sample with a small initial amount.
Owner:HANGZHOU YUEZHEN BIOTECHNOLOGY CO LTD

Anti-Listeria monocytogenes MurA protein nano antibody and application thereof

The invention discloses a nano antibody for resisting a listeria monocytogenes MurA protein and application of the nano antibody, and relates to the technical field of biology. The amino acid sequence of the nano antibody is as shown in SEQ ID NO.3. MurA protein of prokaryotically expressed listeria monocytogenes is used as an immunogen to immunize alpaca, total RNA of peripheral blood lymphocytes is extracted, VHH fragments are amplified through reverse transcription and two rounds of nested PCR, the VHH fragments and a pComb3Xss vector are converted into TG1 competent cells after enzyme digestion and connection, and a phage display technology is used for three rounds of elutriation, so that the total RNA of the listeria monocytogenes is obtained. The nanometer antibody for resisting the listeria monocytogenes MurA protein is successfully screened out. The nano antibody can specifically recognize MurA protein and whole listeria monocytogenes, and the immunocolorimetric sensor based on thiolated bacteriophage induced colloidal gold aggregation, which is established by utilizing the nano antibody, is strong in specificity, high in sensitivity and low in detection limit, and can greatly shorten the detection time.
Owner:JILIN UNIVERSITY

SiRNA (small interfering Ribonucleic Acid) for enabling bivolcanic variety silkworms to lay non-diapause eggs as well as preparation method and application of siRNA

The invention discloses siRNA (small interfering Ribonucleic Acid) for enabling bivolcanic variety silkworms to lay non-diapause eggs as well as a preparation method and application of the siRNA. The method comprises the following steps: extracting total RNA (Ribonucleic Acid) from fat bodies of five-year-old silkworms on the third day, performing reverse transcription to obtain first-chain cDNA (Complementary Deoxyribonucleic Acid), performing amplification by taking the first-chain cDNA as a template to obtain BmKurtz cDNA, performing PCR (Polymerase Chain Reaction) amplification and enzyme digestion by taking the first-chain cDNA as a template, connecting an obtained fragment into a carrier to obtain pFLAG-BmKurtz, performing PCR amplification by taking the obtained fragment as a template to obtain a reaction template, mixing the reaction template with a reaction solution, reacting, and further treating to obtain BmKurtz siRNA; the BmKurtz siRNA liquid is injected into the belly of a female silkworm chrysalis of a bigelous variety bombyx mori producing diapause eggs, normal mating is carried out after moth formation, and non-diapause eggs are produced. The method plays a positive role in researching the silkworm embryo diapause mechanism, further utilizing silkworm embryo diapause to carry out technical innovation and economic benefit improvement of the traditional sericulture industry and the like.
Owner:ZHEJIANG UNIV

MicroRNA fluorescent biosensor for quantitatively detecting colorectal cancer as well as preparation method and application of microRNA fluorescent biosensor

The invention provides a microRNA fluorescent biosensor for quantitative detection of colorectal cancer. The microRNA fluorescent biosensor comprises a microRNA padlock probe for colorectal cancer, diethyl pyrocarbonate treatment water, T4DNA ligase, T7RNA polymerase, an rNTPs mixture, DNA endonuclease, a signal probe, a biological buffer solution and a Simply P total RNA extraction kit. According to the invention, simultaneous detection of a plurality of miRNAs (miR-21, miR-17, miR-31 and miR-92a) related to colorectal cancer can be realized; the adopted fluorescent probe has universal capability and can be applied to other gene detection by changing a target object recognition domain; a promoter is not needed to start transcription, so that the experimental design and operation are simplified.
Owner:RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Construction and application method of wheat yeast two-hybrid cDNA library

The invention provides a construction method and an application method of a wheat yeast two-hybrid cDNA library, and belongs to the technical field of biology. The invention provides a construction method of a yeast two-hybrid cDNA library, which comprises the following steps: extracting total RNA, separating mRNA, converting into cDNA, transferring into escherichia coli competent cells through a series of reactions to obtain a cDNA primary library bacterial liquid, separating primary library plasmids, and obtaining a yeast two-hybrid cDNA library bacterial liquid through an LR recombination reaction and conversion of the escherichia coli competent cells. A high-quality wheat variety Zheng wheat 158 is taken as a research material, wheat gliadin genes Tagli-gamma-1 and Tagli-gamma-11 are cloned, a corresponding bait vector is constructed, the interaction protein is screened from a cDNA library of the Zheng wheat 158 by utilizing a yeast two-hybrid technology, and a foundation is laid for carrying out interaction protein screening of genes related to wheat quality and analyzing a regulation mechanism of the interaction protein in a later period.
Owner:HENAN ACAD OF AGRI SCI XIAOMAI INST

Computational biology research data analysis and display method

The invention relates to the technical field of biological research data analysis, and discloses a computational biological research data analysis display method, which comprises the following steps of: extracting total RNA (Ribonucleic Acid) from biological tissues or cells, reversely transcribing the RNA into cDNA (Complementary Deoxyribonucleic Acid), constructing a library, and sequencing the library by utilizing a high-throughput sequencing platform to obtain a large number of short sequences. According to the method, the number of the short sequences mapped to the same genome coordinate interval is compared and the threshold value is judged, so that the abnormal repeated area can be effectively identified, whether the gene expression difference result is credible or not is clearly judged, and when the number of the abnormal sequences exceeds the preset repeated sequence threshold value, the influence operation of the repeated sequences is eliminated, and the accuracy of the gene expression difference result is improved. That is to say, completely identical and overlapped short sequences are removed under the condition that the FPKM value is relatively high, and the updating result is compared again, so that the problem of expression quantity distortion caused by repeated reckoning can be corrected.
Owner:BURDOCK BIOTECHNOLOGY(DEZHOU) CO LTD

Molecular marker for resistance of chlamydomonas reinhardtii to diflufenican as well as application and detection method of molecular marker

The invention discloses a molecular marker of resistance of chlamydomonas reinhardtii to diflufenican and application of the molecular marker to classification of sensitive populations and resistant populations of the chlamydomonas reinhardtii to the diflufenican, and the molecular marker is CrPDSA113V mutation or CrPDSAF269Y mutation, namely Ala-1113-Val mutation or Ph-269-Tyr mutation. The detection method comprises the following steps: firstly, extracting total DNA and total RNA of chlamydomonas reinhardtii to be detected, taking the total DNA and CDNA after reverse transcription as templates, carrying out PCR (Polymerase Chain Reaction) amplification by using the specific primer pair to obtain PDS gene segments of an amplification product, analyzing whether the PCR amplification product contains the molecular marker or not, and if the PCR amplification product contains the molecular marker, judging whether the PCR amplification product contains the molecular marker or not. Whether the chlamydomonas reinhardtii to be detected is a diflufenican sensitive population or a diflufenican resistant population can be judged. The molecular marker of the resistance of the chlamydomonas reinhardtii to the diflufenican is determined for the first time, and a rapid molecular detection means is provided for the resistance of the chlamydomonas reinhardtii to the diflufenican.
Owner:GANSU AGRI UNIV

RT-qPCR detection method and application of the distribution of human mesenchymal stem cells in mice

ActiveCN114908147BMicrobiological testing/measurementStem cell productTotal rna
The present invention relates to an RT-qPCR detection method and application for the distribution of human mesenchymal stem cells in mice, belonging to the field of biomedicine technology. The RT-qPCR detection method comprises the following steps: sampling: taking organ tissues of mice injected with human mesenchymal stem cells, extracting their total RNA for testing; detection: using real-time fluorescence quantitative PCR to detect the human mesenchymal stem cell-specific protein gene sequence in the above-mentioned total RNA to obtain the distribution of human mesenchymal stem cells in mice. The above-mentioned detection method can achieve the purpose of quickly and accurately detecting the in vivo distribution of multiple tissues at different time points, providing data support for the selection of stem cell products, and being used in the evaluation of the distribution of stem cells in the body.
Owner:NAT INST FOR FOOD & DRUG CONTROL

Rapid sterile detection method and kit based on 16S / 18S rRNA-cDNA digital PCR technology

The invention discloses a rapid sterile detection method and kit based on a 16S / 18S rRNA-cDNA digital PCR technology, and the method comprises the following steps: S1, extracting total RNA in a to-be-detected sample to obtain bacteria 16S rRNA and fungi 18S rRNA; s2, carrying out reverse transcription on the bacterium 16S rRNA and the fungus 18S rRNA to obtain a stable cDNA (complementary deoxyribonucleic acid) fragment; and S3, carrying out digital PCR amplification by taking the cDNA fragment as a template, and judging whether bacterial contamination exists or not according to an amplification result so as to realize rapid sterile detection. According to the characteristics of high conservative and high copy of bacteria 16S rRNA / fungi 18S rRNA, 30 sets of universal primer probe combinations are verified, and gt can be covered by selecting the optimal two sets of primer probe combinations; 99.99% of common pollution bacteria / fungi in clinic and pharmacy, and no cross amplification with mitochondrial rRNA of mammals such as human, hamster, cattle and the like.
Owner:HANGZHOU QINHAN PHARM TECH CO LTD +1

Anti-CD30 rabbit Fab antibody as well as preparation method and application thereof

The invention provides an anti-CD30 rabbit Fab antibody as well as a preparation method and application thereof. Human CD30 protein is expressed through in-vitro recombination, a rabbit is immunized for three times by using the CD30 protein, peripheral blood lymphocytes are separated out, total RNA of the peripheral blood lymphocytes is extracted, the peripheral blood lymphocytes are reversely transcribed into cDNA, the cDNA is taken as a template, and a Fab sequence is amplified by using a specific primer; according to the invention, a rabbit Fc structural domain is used as an antigen, a Fab antibody capable of being combined with CD30 protein is obtained by screening through a yeast display technology, a Fab sequence is combined with the rabbit Fc structural domain to obtain high-purity fusion protein, and the fact that the Fab antibody has relatively strong activity with CD30 and has specific binding capacity with tumor cells is verified at the cellular level.
Owner:WUHAN ELABSCIENCE BIOTECHNOLOGY CO LTD +1

Nitrate ion transport channel gene PbrSLAH3b and application thereof in promoting growth of pear pollen tube

The invention belongs to the technical field of plant genetic engineering, and particularly discloses a nitrate ion transport channel gene PbrSLAH3b and application of the nitrate ion transport channel gene PbrSLAH3b in promoting growth of pear pollen tubules. The method comprises the following steps: extracting total RNA (Ribonucleic Acid) of Dangshan pears from pollen of Dangshan pears; carrying out reverse transcription on the RNA to obtain cDNA (complementary deoxyribonucleic acid); and by taking the cDNA as a template, carrying out amplification to obtain the pear pollen tube nitrate transport channel gene PbrSLAH3b, the PbrSLAH3b gene provided by the invention belongs to a slow anion channel SLAC / SLAH family member, the PbrSLAH3b is remarkably up-regulated in expression in the early growth stage of a pollen tube, and the PbrSLAH3b is positioned in a plasma membrane. The invention verifies that PbrSLAH3b can form a functional anion channel with NO3 <-> selectivity under the condition of not depending on proton gradient or phosphorylation state, and the PbrSLAH3b has relatively strong selectivity on NO3 <->. Therefore, the PbrSLAH3b gene can mediate the absorption and transport of the pollen tube to NO3 <-> and maintain the polarity growth directivity of the pollen tube, and has important application value for revealing the ion regulation mechanism of the growth of the fruit tree pollen tube and improving the reproductive development of the fruit tree.
Owner:HUAIYIN INSTITUTE OF TECHNOLOGY

Plant tissue collection, RNA extraction and genetic analysis

Methods of extracting ribonucleic acid from plant tissue involve treating multiple groups of plant seeds with different plant growth regulators. Each group of plant seeds can be treated with a different plant growth regulator. Methods further involve germinating the plant seeds to form seedlings, harvesting tissue samples from subgroups within each group of plant seeds and seedlings at different timepoints, and extracting total RNA from each harvested tissue sample. Methods can also involve sequencing the extracted RNA, determining an expression level of a plurality of genes relative to a negative control, and identifying a subset of differentially expressed genes at each distinct timepoint.
Owner:WINFIELD SOLUTIONS LLC

Micro-chromosome state characterization cell model for drug screening and new application of compound in resisting hepatitis B virus

The invention discloses a mini-chromosome state characterization cell model for drug screening. The mini-chromosome state characterization cell model is a transfected cell obtained by co-transfecting a hepatocyte line with prcccDNA-HiBiT-HBx and a plasmid Cre; the invention also discloses an application of the compound C20H14F3N3S or the pharmaceutically acceptable salt thereof in preparation of an HBV (hepatitis B virus) inhibitor or a medicine for treating hepatitis B virus infectious diseases or symptoms. According to the invention, a novel anti-hepatitis B virus small molecule compound is screened by utilizing a constructed cell model, and experiments prove that the novel anti-hepatitis B virus small molecule compound can obviously reduce the expression levels of HBV total RNAs, HBeAg, HBV pgRNA and HBV nucleoprotein.
Owner:CHONGQING MEDICAL UNIVERSITY

Preparation method and application of TCR-T targeting SARS-Cov-2

The invention relates to a method for preparing a TCR-T targeting SARS-Cov-2 and its application, comprising: 1) synthesizing a SARS-Cov-2 antigen peptide XG2; 2) stimulating the peripheral blood of volunteers with HLA-A*02:01 with antigen peptides to obtain SARS-Cov-2 specific T cells; 3) extracting total RNA of SARS-Cov-2 specific T cells, reverse transcribing to obtain cDNA, and performing NSG sequencing after multiple PCR to obtain an immune repertoire; 4) performing bioinformatics analysis on the immune repertoire to obtain a specific CDR3 sequence; 5) using the specific CDR3 sequence to clone and construct a TCR-T lentiviral vector, which is used to target and identify cells infected with SARS-Cov-2 and to kill them.
Owner:XIAMEN UNIV

Fish creatine kinase allergenicity and immune cross reactivity analysis method

The invention provides a fish creatine kinase sensitization and immune cross reactivity analysis method which comprises the following steps: preparing a fish muscle water-soluble protein crude extract, separating 40-45kDa protein components in the fish muscle crude extract through SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis), and screening a target sensitization protein combined with IgE / IgG through immunoblotting; the method comprises the following steps: extracting total RNA of grass carp and synthesizing cDNA, designing a creatine kinase specific primer for amplification to obtain a creatine kinase gene sequence, and carrying out bioinformatics analysis after sequencing verification; the method comprises the following steps: cloning a creatine kinase gene to an expression vector, transforming escherichia coli BL21, performing IPTG induced expression, and performing urea gradient dialysis renaturation on an inclusion body to obtain the recombinant grass carp creatine kinase. Detecting the IgE binding activity of the recombinant grass carp creatine kinase and the serum of the allergic patient through dot hybridization; the IgG cross reactivity of the recombinant grass carp creatine kinase and the blue crab arginine kinase is verified through indirect ELISA; the IgE cross reaction degree of the recombined grass carp creatine kinase and the blue crab arginine kinase is quantified through inhibitory dot hybridization.
Owner:XIAMEN HUAXIA UNIV